doi:10.48130/bpr-0025-0044

[1]

Ackers I, Malgor R. 2018. Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases. Diabetes & Vascular Disease Research 15(1):3−13

doi: 10.1177/1479164117738442

[2]

Fletcher B, Gulanick M, Lamendola C. 2002. Risk factors for type 2 diabetes mellitus. The Journal of Cardiovascular Nursing 16(2):17−23

doi: 10.1097/00005082-200201000-00003

[3]

Shou JW, Shaw PC. 2023. Berberine reduces lipid accumulation in obesity via mediating transcriptional function of PPARδ. International Journal of Molecular Sciences 24(14):11600

doi: 10.3390/ijms241411600

[4]

Zhang H, Zhou XD, Shapiro MD, Lip GYH, Tilg H, et al. 2024. Global burden of metabolic diseases, 1990–2021. Metabolism 160:155999

doi: 10.1016/j.metabol.2024.155999

[5]

Luo Q, Luo L, Zhao J, Wang Y, Luo H. 2024. Biological potential and mechanisms of Tea's bioactive compounds: an updated review. Journal of Advanced Research 65:345−363

doi: 10.1016/j.jare.2023.12.004

[6]

Bokuchava MA, Skobeleva NI, Sanderson GW. 1980. The biochemistry and technology of tea manufacture. C R C Critical Reviews in Food Science and Nutrition 12(4):303−370

doi: 10.1080/10408398009527280

[7]

Yang J, Mao QX, Xu HX, Ma X, Zeng CY. 2014. Tea consumption and risk of type 2 diabetes mellitus: a systematic review and meta-analysis update. BMJ Open 4(7):e005632

doi: 10.1136/bmjopen-2014-005632

[8]

Wan C, Ouyang J, Li M, Rengasamy KRR, Liu Z. 2024. Effects of green tea polyphenol extract and epigallocatechin-3-O-gallate on diabetes mellitus and diabetic complications: recent advances. Critical Reviews in Food Science and Nutrition 64(17):5719−5747

doi: 10.1080/10408398.2022.2157372

[9]

Wang C, Hu M, Yi Y, Wen X, Lv C, et al. 2022. Multiomic analysis of dark tea extract on glycolipid metabolic disorders in db/db mice. Frontiers in Nutrition 9:1006517

doi: 10.3389/fnut.2022.1006517

[10]

Khan N, Mukhtar H. 2007. Tea polyphenols for health promotion. Life Sciences 81(7):519−533

doi: 10.1016/j.lfs.2007.06.011

[11]

Dai F, Chen WF, Zhou B. 2008. Antioxidant synergism of green tea polyphenols with α-tocopherol and L-ascorbic acid in SDS micelles. Biochimie 90(10):1499−1505

doi: 10.1016/j.biochi.2008.05.007

[12]

Tanaka T, Matsuo Y. 2020. Production mechanisms of black tea polyphenols. Chemical and Pharmaceutical Bulletin 68(12):1131−1142

doi: 10.1248/cpb.c20-00295

[13]

Neeland IJ, Lim S, Tchernof A, Gastaldelli A, Rangaswami J, et al. 2024. Metabolic syndrome. Nature Reviews Disease Primers 10:77

doi: 10.1038/s41572-024-00563-5

[14]

Zhang S, Wei Y, Wang C. 2022. Impacts of an exercise intervention on the health of pancreatic beta-cells: a review. International Journal of Environmental Research and Public Health 19(12):7229

doi: 10.3390/ijerph19127229

[15]

Wallemacq C. 2019. Statins and new-onset diabetes : benefit-risk balance. Revue Medicale Suisse 15(659):1454−1457

[16]

Hou BY, Zhao YR, Ma P, Xu CY, He P, et al. 2020. Hypoglycemic activity of puerarin through modulation of oxidative stress and mitochondrial function via AMPK. Chinese Journal of Natural Medicines 18(11):818−826

doi: 10.1016/S1875-5364(20)60022-X

[17]

Wada Y, Takata A, Ikemoto T, Morine Y, Imura S, et al. 2019. The protective effect of epigallocatechin 3-gallate on mouse pancreatic islets via the Nrf2 pathway. Surgery Today 49(6):536−545

doi: 10.1007/s00595-019-1761-0

[18]

Hininger-Favier I, Benaraba R, Coves S, Anderson RA, Roussel AM. 2009. Green tea extract decreases oxidative stress and improves insulin sensitivity in an animal model of insulin resistance, the fructose-fed rat. Journal of the American College of Nutrition 28(4):355−361

doi: 10.1080/07315724.2009.10718097

[19]

Hossain U, Das AK, Ghosh S, Sil PC. 2020. An overview on the role of bioactive α-glucosidase inhibitors in ameliorating diabetic complications. Food and Chemical Toxicology 145:111738

doi: 10.1016/j.fct.2020.111738

[20]

Yang X, Kong F. 2016. Evaluation of the in vitro α-glucosidase inhibitory activity of green tea polyphenols and different tea types. Journal of the Science of Food and Agriculture 96(3):777−782

doi: 10.1002/jsfa.7147

[21]

Zhu T, Li M, Zhu M, Liu X, Huang K, et al. 2022. Epigallocatechin-3-gallate alleviates type 2 diabetes mellitus via β-cell function improvement and insulin resistance reduction. Iranian Journal of Basic Medical Sciences 25(4):483−488

doi: 10.22038/ijbms.2022.58591.13016

[22]

Jia X, Mao D, Guo J, Ke J, Zhu Y, et al. 2024. Epigallocatechin gallate attenuated high glucose-induced pancreatic beta cell dysfunction by modulating DRP1-mediated mitochondrial apoptosis pathways. Scientific Reports 14:16809

doi: 10.1038/s41598-024-67867-0

[23]

Zhang C, Li X, Hu X, Xu Q, Zhang Y, et al. 2021. Epigallocatechin-3-gallate prevents inflammation and diabetes-Induced glucose tolerance through inhibition of NLRP3 inflammasome activation. International Immunopharmacology 93:107412

doi: 10.1016/j.intimp.2021.107412

[24]

Zeng H, Liu C, Wan L, Peng L, Wen S, et al. 2024. (–)-Epicatechin ameliorates type 2 diabetes mellitus by reshaping the gut microbiota and gut–liver axis in GK rats. Food Chemistry 447:138916

doi: 10.1016/j.foodchem.2024.138916

[25]

Wu X, Yang M, He Y, Wang F, Kong Y, et al. 2022. EGCG-derived polymeric oxidation products enhance insulin sensitivity in db/db mice. Redox Biology 51:102259

doi: 10.1016/j.redox.2022.102259

[26]

Tong T, Ren N, Soomi P, Wu J, Guo N, et al. 2018. Theaflavins improve insulin sensitivity through regulating mitochondrial biosynthesis in palmitic acid-induced HepG2 cells. Molecules 23(12):3382

doi: 10.3390/molecules23123382

[27]

Cheng L, Wei Y, Peng L, Wei K, Liu Z, et al. 2024. State-of-the-art review of theabrownins: from preparation, structural characterization to health-promoting benefits. Critical Reviews in Food Science and Nutrition 64(31):11321−11340

doi: 10.1080/10408398.2023.2236701

[28]

Lu Z, Zheng Y, Zheng J, Liang Q, Zhen Q, et al. 2024. Theabrownin from Fu Brick tea ameliorates high-fat induced insulin resistance, hepatic steatosis, and inflammation in mice by altering the composition and metabolites of gut microbiota. Food & Function 15(8):4421−4435

doi: 10.1039/D3FO05459D

[29]

Jackson VM, Breen DM, Fortin JP, Liou A, Kuzmiski JB, et al. 2015. Latest approaches for the treatment of obesity. Expert Opinion on Drug Discovery 10(8):825−839

doi: 10.1517/17460441.2015.1044966

[30]

Derosa G, Maffioli P. 2012. Anti-obesity drugs: a review about their effects and their safety. Expert Opinion on Drug Safety 11(3):459−471

doi: 10.1517/14740338.2012.675326

[31]

Berge J, Hjelmesaeth J, Hertel JK, Gjevestad E, Småstuen MC, et al. 2021. Effect of aerobic exercise intensity on energy expenditure and weight loss in severe obesity-a randomized controlled trial. Obesity 29(2):359−369

doi: 10.1002/oby.23078

[32]

Liao JT, Huang YW, Hou CY, Wang JJ, Wu CC, et al. 2023. D-limonene promotes anti-obesity in 3T3-L1 adipocytes and high-calorie diet-induced obese rats by activating the AMPK signaling pathway. Nutrients 15(2):267

doi: 10.3390/nu15020267

[33]

Hwang JT, Kim SH, Lee MS, Kim SH, Yang HJ, et al. 2007. Anti-obesity effects of ginsenoside Rh2 are associated with the activation of AMPK signaling pathway in 3T3-L1 adipocyte. Biochemical and Biophysical Research Communications 364(4):1002−1008

doi: 10.1016/j.bbrc.2007.10.125

[34]

Li SZ, Zeng SL, Liu EH. 2022. Anti-obesity natural products and gut microbiota. Food Research International 151:110819

doi: 10.1016/j.foodres.2021.110819

[35]

Zhang X, You Y, Wang L, Ai C, Huang L, et al. 2022. Anti-obesity effects of Laminaria japonica fucoidan in high-fat diet-fed mice vary with the gut microbiota structure. Food & Function 13(11):6259−6270

doi: 10.1039/D2FO00480A

[36]

Nakabayashi H, Hashimoto T, Ashida H, Nishiumi S, Kanazawa K. 2008. Inhibitory effects of caffeine and its metabolites on intracellular lipid accumulation in murine 3T3-L1 adipocytes. BioFactors 34(4):293−302

doi: 10.3233/BIO-2009-1083

[37]

Yang CS, Zhang J, Zhang L, Huang J, Wang Y. 2016. Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. Molecular Nutrition & Food Research 60(1):160−174

doi: 10.1002/mnfr.201500428

[38]

Dey P, Sasaki GY, Wei P, Li J, Wang L, et al. 2019. Green tea extract prevents obesity in male mice by alleviating gut dysbiosis in association with improved intestinal barrier function that limits endotoxin translocation and adipose inflammation. The Journal of Nutritional Biochemistry 67:78−89

doi: 10.1016/j.jnutbio.2019.01.017

[39]

Tian B, Huang P, Pan Y, Gu H, Yang K, et al. 2024. Tea polyphenols reduced obesity by modulating gut microbiota-SCFAs-barrier and inflammation in high-fat diet-induced mice. Molecular Nutrition & Food Research 68(24):e2400685

doi: 10.1002/mnfr.202400685

[40]

Cunha CA, Lira FS, Rosa Neto JC, Pimentel GD, Souza GIH, et al. 2013. Green tea extract supplementation induces the lipolytic pathway, attenuates obesity, and reduces low-grade inflammation in mice fed a high-fat diet. Mediators of Inflammation 2013:635470

doi: 10.1155/2013/635470

[41]

Rocha A, Bolin AP, Cardoso CAL, Otton R. 2016. Green tea extract activates AMPK and ameliorates white adipose tissue metabolic dysfunction induced by obesity. European Journal of Nutrition 55(7):2231−2244

doi: 10.1007/s00394-015-1033-8

[42]

Wang L, Zeng B, Liu Z, Liao Z, Zhong Q, et al. 2018. Green tea polyphenols modulate colonic microbiota diversity and lipid metabolism in high-fat diet treated HFA mice. Journal of Food Science 83(3):864−873

doi: 10.1111/1750-3841.14058

[43]

Bolin AP, Sousa-Filho CPB, dos Santos GTN, Ferreira LT, de Andrade PBM, et al. 2020. Adipogenic commitment induced by green tea polyphenols remodel adipocytes to a thermogenic phenotype. The Journal of Nutritional Biochemistry 83:108429

doi: 10.1016/j.jnutbio.2020.108429

[44]

Bolin AP, Sousa-Filho CPB, Marinovic MP, Rodrigues AC, Otton R. 2020. Polyphenol-rich green tea extract induces thermogenesis in mice by a mechanism dependent on adiponectin signaling. The Journal of Nutritional Biochemistry 78:108322

doi: 10.1016/j.jnutbio.2019.108322

[45]

Tian C, Ye X, Zhang R, Long J, Ren W, et al. 2013. Green tea polyphenols reduced fat deposits in high fat-fed rats via erk1/2-PPARγ-adiponectin pathway. PLoS One 8(1):e53796

doi: 10.1371/journal.pone.0053796

[46]

Hsu TF, Kusumoto A, Abe K, Hosoda K, Kiso Y, et al. 2006. Polyphenol-enriched oolong tea increases fecal lipid excretion. European Journal of Clinical Nutrition 60(11):1330−1336

doi: 10.1038/sj.ejcn.1602464

[47]

Zhu MZ, Zhou F, Ouyang J, Wang QY, Li YL, et al. 2021. Combined use of epigallocatechin-3-gallate (EGCG) and caffeine in low doses exhibits marked anti-obesity synergy through regulation of gut microbiota and bile acid metabolism. Food & Function 12(9):4105−4116

doi: 10.1039/D0FO01768J

[48]

Zhang S, Xie H, Pan P, Wang Q, Yang B, et al. 2024. EGCG alleviates heat-stress-induced fat deposition by targeting HSP70 through activation of AMPK-SIRT1-PGC-1α in porcine subcutaneous preadipocytes. Biochemical Pharmacology 225:116250

doi: 10.1016/j.bcp.2024.116250

[49]

Chen CP, Su TC, Yang MJ, Chen WT, Siao AC, et al. 2022. Green tea epigallocatechin gallate suppresses 3T3-L1 cell growth via microRNA-143/MAPK7 pathways. Experimental Biology and Medicine 247(18):1670−1679

[50]

Choi C, Song HD, Son Y, Cho YK, Ahn SY, et al. 2020. Epigallocatechin-3-gallate reduces visceral adiposity partly through the regulation of Beclin1-dependent autophagy in white adipose tissues. Nutrients 12(10):3072

doi: 10.3390/nu12103072

[51]

Klaus S, Pültz S, Thöne-Reineke C, Wolfram S. 2005. Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. International Journal of Obesity 29(6):615−623

doi: 10.1038/sj.ijo.0802926

[52]

Rothenberg DO, Zhou C, Zhang L. 2018. A review on the weight-loss effects of oxidized tea polyphenols. Molecules 23(5):1176

doi: 10.3390/molecules23051176

[53]

Wang S, Huang Y, Xu H, Zhu Q, Lu H, et al. 2017. Oxidized tea polyphenols prevent lipid accumulation in liver and visceral white adipose tissue in rats. European Journal of Nutrition 56(6):2037−2048

doi: 10.1007/s00394-016-1241-x

[54]

Fang Y, Wang J, Cao Y, Liu W, Duan L, et al. 2024. The antiobesity effects and potential mechanisms of theaflavins. Journal of Medicinal Food 27(1):1−11

doi: 10.1089/jmf.2023.K.0180

[55]

Cai X, Liu Z, Dong X, Wang Y, Zhu L, et al. 2021. Hypoglycemic and lipid lowering effects of theaflavins in high-fat diet-induced obese mice. Food & Function 12(20):9922−9931

doi: 10.1039/D1FO01966J

[56]

Tung YC, Liang ZR, Yang MJ, Ho CT, Pan MH. 2022. Oolong tea extract alleviates weight gain in high-fat diet-induced obese rats by regulating lipid metabolism and modulating gut microbiota. Food & Function 13(5):2846−2856

doi: 10.1039/D1FO03356E

[57]

Byrne CD, Targher G. 2015. NAFLD: a multisystem disease. Journal of Hepatology 62(1):S47−S64

doi: 10.1016/j.jhep.2014.12.012

[58]

Gofton C, Upendran Y, Zheng MH, George J. 2023. MAFLD: how is it different from NAFLD? Clinical and Molecular Hepatology 29:S17−S31

doi: 10.3350/cmh.2022.0367

[59]

Beygi M, Ahi S, Zolghadri S, Stanek A. 2024. Management of metabolic-associated fatty liver disease/metabolic dysfunction-associated steatotic liver disease: from medication therapy to nutritional interventions. Nutrients 16(14):2220

doi: 10.3390/nu16142220

[60]

Guo X, Yin X, Liu Z, Wang J. 2022. Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment. International Journal of Molecular Sciences 23(24):15489

doi: 10.3390/ijms232415489

[61]

Farzanegi P, Dana A, Ebrahimpoor Z, Asadi M, Ali Azarbayjani M. 2019. Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): roles of oxidative stress and inflammation. European Journal of Sport Science 19(7):994−1003

doi: 10.1080/17461391.2019.1571114

[62]

Zheng N, Wang H, Zhu W, Li Y, Li H. 2024. Astragalus polysaccharide attenuates nonalcoholic fatty liver disease through THDCA in high-fat diet-fed mice. Journal of Ethnopharmacology 320:117401

doi: 10.1016/j.jep.2023.117401

[63]

Guo F, Xiong H, Tsao R, Shahidi F, Wen X, et al. 2023. Green pea (Pisum sativum L.) hull polyphenol extract alleviates NAFLD through VB6/TLR4/NF-κB and PPAR pathways. Journal of Agricultural and Food Chemistry 71(43):16067−16078

doi: 10.1021/acs.jafc.3c02337

[64]

Fang C, Cai X, Hayashi S, Hao S, Sakiyama H, et al. 2019. Caffeine-stimulated muscle IL-6 mediates alleviation of non-alcoholic fatty liver disease. Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids 1864(3):271−280

doi: 10.1016/j.bbalip.2018.12.003

[65]

Karolczak D, Seget M, Bajerska J, Błaszczyk A, Drzymała-Czyż S, et al. 2019. Green tea extract prevents the development of nonalcoholic liver steatosis in rats fed a high-fat diet. Polish Journal of Pathology 70(4):295−303

doi: 10.5114/pjp.2019.93132

[66]

Mi Y, Qi G, Gao Y, Li R, Wang Y, et al. 2017. (-)-Epigallocatechin-3-gallate ameliorates insulin resistance and mitochondrial dysfunction in HepG2 cells: involvement of Bmal1. Molecular Nutrition & Food Research 61(12):1700440

doi: 10.1002/mnfr.201700440

[67]

Wen JJ, Li MZ, Chen CH, Hong T, Yang JR, et al. 2023. Tea polyphenol and epigallocatechin gallate ameliorate hyperlipidemia via regulating liver metabolism and remodeling gut microbiota. Food Chemistry 404:134591

doi: 10.1016/j.foodchem.2022.134591

[68]

Huang J, Feng S, Liu A, Dai Z, Wang H, et al. 2018. Green tea polyphenol EGCG alleviates metabolic abnormality and fatty liver by decreasing bile acid and lipid absorption in mice. Molecular Nutrition & Food Research 62(4):1700696

doi: 10.1002/mnfr.201700696

[69]

Yang M, Yan R, Sha R, Wang X, Zhou S, et al. 2024. Epigallocatechin gallate alleviates non-alcoholic fatty liver disease through the inhibition of the expression and activity of Dipeptide kinase 4. Clinical Nutrition 43(8):1769−1780

doi: 10.1016/j.clnu.2024.06.018

[70]

Santamarina AB, Oliveira JL, Silva FP, Carnier J, Mennitti LV, et al. 2015. Green tea extract rich in epigallocatechin-3-gallate prevents fatty liver by AMPK activation via LKB1 in mice fed a high-fat diet. PLoS One 10(11):e0141227

doi: 10.1371/journal.pone.0141227

[71]

Sakata R, Nakamura T, Torimura T, Ueno T, Sata M. 2013. Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study. International Journal of Molecular Medicine 32(5):989−994

doi: 10.3892/ijmm.2013.1503

[72]

Luo XY, Takahara T, Hou J, Kawai K, Sugiyama T, et al. 2012. Theaflavin attenuates ischemia–reperfusion injury in a mouse fatty liver model. Biochemical and Biophysical Research Communications 417(1):287−293

doi: 10.1016/j.bbrc.2011.11.102

[73]

Zhou C, Zhang W, Lin H, Zhang L, Wu F, et al. 2022. Effect of theaflavin-3, 3'-digallate on leptin-deficient induced nonalcoholic fatty liver disease might be related to lipid metabolism regulated by the Fads1/PPARδ/Fabp4 axis and gut microbiota. Frontiers in Pharmacology 13:925264

doi: 10.3389/fphar.2022.925264

[74]

Wu M, Li X, Wang S, Yang S, Zhao R, et al. 2020. Polydatin for treating atherosclerotic diseases: a functional and mechanistic overview. Biomedicine & Pharmacotherapy 128:110308

doi: 10.1016/j.biopha.2020.110308

[75]

Wang WZ, Liu C, Luo JQ, Lei LJ, Chen MH, et al. 2024. A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis. Acta Pharmacologica Sinica 45(10):2119−2133

doi: 10.1038/s41401-024-01305-9

[76]

Babaev VR, Hebron KE, Wiese CB, Toth CL, Ding L, et al. 2014. Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice. Journal of Lipid Research 55(11):2296−2308

doi: 10.1194/jlr.M050633

[77]

Burke AC, Sutherland BG, Telford DE, Morrow MR, Sawyez CG, et al. 2019. Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr^−/− mice. Atherosclerosis 286:60−70

doi: 10.1016/j.atherosclerosis.2019.05.009

[78]

Kattoor AJ, Pothineni NVK, Palagiri D, Mehta JL. 2017. Oxidative stress in atherosclerosis. Current Atherosclerosis Reports 19(11):42

doi: 10.1007/s11883-017-0678-6

[79]

Kong P, Cui ZY, Huang XF, Zhang DD, Guo RJ, et al. 2022. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduction and Targeted Therapy 7:131

doi: 10.1038/s41392-022-00955-7

[80]

Cheng YC, Sheen JM, Hu WL, Hung YC. 2017. Polyphenols and oxidative stress in atherosclerosis-related ischemic heart disease and stroke. Oxidative Medicine and Cellular Longevity 2017(1):8526438

doi: 10.1155/2017/8526438

[81]

Huang SC, Kao YH, Shih SF, Tsai MC, Lin CS, et al. 2021. Epigallocatechin-3-gallate exhibits immunomodulatory effects in human primary T cells. Biochemical and Biophysical Research Communications 550:70−76

doi: 10.1016/j.bbrc.2021.02.132

[82]

Yu J, Li W, Xiao X, Huang Q, Yu J, et al. 2021. (–)-Epicatechin gallate blocks the development of atherosclerosis by regulating oxidative stress in vivo and in vitro. Food & Function 12(18):8715−8727

doi: 10.1039/d1fo00846c

[83]

Yu J, Zhou L, Song H, Huang Q, Yu J, et al. 2023. (–)-Epicatechin gallate blocked cellular foam formation in atherosclerosis by modulating CD36 expression in vitro and in vivo. Food & Function 14(5):2444−2458

doi: 10.1039/d2fo03218j

[84]

Liao ZL, Zeng BH, Wang W, Li GH, Wu F, et al. 2016. Impact of the consumption of tea polyphenols on early atherosclerotic lesion formation and intestinal bifidobacteria in high-fat-fed ApoE−/− mice. Frontiers in Nutrition 3:42

doi: 10.3389/fnut.2016.00042

[85]

Tijburg LBM, Wiseman SA, Meijer GW, Weststrate JA. 1997. Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits. Atherosclerosis 135(1):37−47

doi: 10.1016/S0021-9150(97)00139-1

[86]

Ding S, Jiang J, Yu P, Zhang G, Zhang G, et al. 2017. Green tea polyphenol treatment attenuates atherosclerosis in high-fat diet-fed apolipoprotein E-knockout mice via alleviating dyslipidemia and up-regulating autophagy. PLoS One 12(8):e0181666

doi: 10.1371/journal.pone.0181666

[87]

Zeng J, Deng Z, Zou Y, Liu C, Fu H, et al. 2021. Theaflavin alleviates oxidative injury and atherosclerosis progress via activating microRNA-24-mediated Nrf2/HO-1 signal. Phytotherapy Research 35(6):3418−3427

doi: 10.1002/ptr.7064

[88]

Becker MA, Jolly M. 2006. Hyperuricemia and associated diseases. Rheumatic Diseases Clinics of North America 32(2):275−293

doi: 10.1016/j.rdc.2006.02.005

[89]

Lioté F. 2003. Hyperuricemia and gout. Current Rheumatology Reports 5(3):227−234

doi: 10.1007/s11926-003-0072-y

[90]

Zhou Y, Zeng Y, Wang R, Pang J, Wang X, et al. 2024. Resveratrol improves hyperuricemia and ameliorates renal injury by modulating the gut microbiota. Nutrients 16(7):1086

doi: 10.3390/nu16071086

[91]

Sun R, Kan J, Cai H, Hong J, Jin C, et al. 2022. In vitro and in vivo ameliorative effects of polyphenols from purple potato leaves on renal injury and associated inflammation induced by hyperuricemia. Journal of Food Biochemistry 46(2):e14049

doi: 10.1111/jfbc.14049

[92]

Wang W, Pang J, Ha EH, Zhou M, Li Z, et al. 2020. Development of novel NLRP3-XOD dual inhibitors for the treatment of gout. Bioorganic & Medicinal Chemistry Letters 30(4):126944

doi: 10.1016/j.bmcl.2019.126944

[93]

Chen G, Tan ML, Li KK, Leung PC, Ko CH. 2015. Green tea polyphenols decreases uric acid level through xanthine oxidase and renal urate transporters in hyperuricemic mice. Journal of Ethnopharmacology 175:14−20

doi: 10.1016/j.jep.2015.08.043

[94]

Wang W, Tan H, Liu H, Peng H, Li X, et al. 2018. Green tea polyphenols protect against preglomerular arteriopathy via the jagged1/Notch1 pathway. American Journal of Translational Research 10(10):3276−3290

[95]

Li F, Liu Y, Xie Y, Liu Z, Zou G. 2020. Epigallocatechin gallate reduces uric acid levels by regulating xanthine oxidase activity and uric acid excretion in vitro and in vivo. Annals of Palliative Medicine 9(2):331−338

doi: 10.21037/apm.2019.11.28

[96]

Yu H, Lou Z, Wu T, Wan X, Huang H, et al. 2024. Mechanisms of epigallocatechin gallate (EGCG) in ameliorating hyperuricemia: insights into gut microbiota and intestinal function in a mouse model. Food & Function 15(11):6068−6081

doi: 10.1039/D4FO01606H

[97]

Wu D, Chen R, Zhang W, Lai X, Sun L, et al. 2022. Tea and its components reduce the production of uric acid by inhibiting xanthine oxidase. Food & Nutrition Research 66:8239

doi: 10.29219/fnr.v66.8239

[98]

Zhao S, Cao H, Sun F, Xu M, Wang X, et al. 2025. Investigating the modulatory effects of Pu-erh tea on the gut microbiota in ameliorating hyperuricemia induced by circadian rhythm disruption. Food & Function 16(7):2669−2686

doi: 10.1039/D4FO05659K

[99]

Chen J, Zheng Y, Gong S, Zheng Z, Hu J, et al. 2023. Mechanisms of theaflavins against gout and strategies for improving the bioavailability. Phytomedicine 114:154782

doi: 10.1016/j.phymed.2023.154782